Allerway

C₂₁H₂₅ClN₂O₃388.90 g/mol

2-[2-[4-[(R)-(4-Chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]acetic acid

Drag to rotate; arrow keys step through the atoms. Structure from PubChem CID 1549000.

Registration

Applicants: 1
Registrations: 1

Applicants and registrations

Applicant	Brands	Dosages	Registrations	Schedule	Leaflets
Dr Reddyæs Laboratories (Pty) LtdCertificate held by Dr. Reddy’s Laboratories (Pty) Ltd.	Allerway	5 mg	430815	Not determined	PI PIL

Variants

Product	Strength and form	Registration	Status	Schedule	Leaflets
Allerway 5 EACH TABLET CONTAINS LEVOCETIRIZINE DIHYDROCHLORIDE 5,0 mg	5 mgFilm-coated tablet	43081543/5.7.1/0815Approved 17 July 2024	Registered	Not determined	PI PIL

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

Listings for this ingredient that could not be applied to this product

S1: Levocetirizine
Consolidated Schedules 06 July 2026, line 775

3 of 9 approved products with this ingredient carry S2 on their leaflet.

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

Background

Loading Wikipedia summary

SAHPRA documents

Professional information (PI)For healthcare professionalsAllerway 5, Dr Reddyæs Laboratories (Pty) Ltd Patient information leaflet (PIL)For patients and carersAllerway 5, Dr Reddyæs Laboratories (Pty) Ltd

These documents come from SAHPRA's PI-PIL repository unless the line under a document says otherwise. Always consult with a healthcare professional for medical advice.

Research articles

Loading PubMed articles